Low Barthel index score is a poor prognostic factor for newly diagnosed multiple myeloma patients

被引:2
|
作者
Geng, Chuanying [1 ]
Yang, Guangzhong [1 ]
Zhou, Huixing [1 ]
Wang, Huijuan [1 ]
Li, Yanchen [1 ]
Leng, Yun [1 ]
Zhang, Zhiyao [1 ]
Jian, Yuan [1 ]
Chen, Wenming [1 ]
机构
[1] Capital Med Univ, Beijing Chaoyang Hosp, Dept Hematol, Beijing 100020, Peoples R China
关键词
Multiple myeloma; Barthel index; Survival; Prognostic factors; GERIATRIC-ASSESSMENT; CRITERIA; FRAILTY;
D O I
10.1007/s10238-023-01002-7
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The basic activities of daily life may affect the prognosis of multiple myeloma (MM) patients and the Barthel index (BI) is currently the most widely used tool to evaluate basic activities of daily life, but few studies have evaluated its prognostic value in MM. We retrospectively enrolled patients with newly diagnosed MM and analyzed the association between the BI and the survival of newly diagnosed MM patients. We totally analyzed 538 patients and found that median overall survival (OS) and progression-free survival (PFS) were significantly shorter in the low BI (<= 85) group compared with the high BI (> 85) group. Univariate Cox proportional hazards regression analysis showed that the low BI was associated with shorter OS and PFS. It was also confirmed that the low BI was poor prognostic factor for OS and PFS in multivariable analyses. In the propensity score matching analysis, patients with low BI also had shorter OS and PFS. Our study suggested that the low BI was a poor prognostic factor for patients with newly diagnosed MM.
引用
收藏
页码:2593 / 2600
页数:8
相关论文
共 50 条
  • [41] T(4;14) Is Not a Poor Prognostic Factor for Newly Diagnosed Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation in New Drug Era
    Geng, Chuanying
    Yang, Guangzhong
    Gao, Wen
    Wang, Huijuan
    Li, Yanchen
    Wu, Yin
    Zhou, Huixing
    Zhang, Zhiyao
    Jian, Yuan
    Chen, Wenming
    BLOOD, 2020, 136
  • [42] Bone marrow Ki-67 index is of prognostic value in newly diagnosed multiple myeloma
    Atrash, Shebli
    Robinson, Myra
    Taneja, Alankrita
    Paul, Barry
    Cassetta, Kristen
    Ndiaye, Ami
    Varga, Cindy
    Block, Jared
    Lipford, Edward H.
    Smith, Elton T.
    McCall, Chad M.
    Thurston, Virginia
    Foureau, David
    Usmani, Saad Z.
    Voorhees, Peter M.
    Bhutani, Manisha
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (03) : 373 - 381
  • [43] Oprozomib in patients with newly diagnosed multiple myeloma
    Hari, Parameswaran
    Matous, Jeffrey V.
    Voorhees, Peter M.
    Shain, Kenneth H.
    Obreja, Mihaela
    Frye, John
    Fujii, Hisaki
    Jakubowiak, Andrzej J.
    Rossi, Davide
    Sonneveld, Pieter
    BLOOD CANCER JOURNAL, 2019, 9 (9)
  • [44] Oprozomib in patients with newly diagnosed multiple myeloma
    Parameswaran Hari
    Jeffrey V. Matous
    Peter M. Voorhees
    Kenneth H. Shain
    Mihaela Obreja
    John Frye
    Hisaki Fujii
    Andrzej J. Jakubowiak
    Davide Rossi
    Pieter Sonneveld
    Blood Cancer Journal, 9
  • [45] Application of the IMWG Frailty Score in Newly Diagnosed Multiple Myeloma Patients in a Brazilian Cohort
    Santos, Valeria Vianna
    Pessoa de Magalhaes Filho, Roberto Jose
    Cibreiros, Mariana
    Marcal, Mariana
    Vasconcellos, Liz
    de Castro, Marcella Gil
    de Albuquerque, Juliano
    Maiolino, Angelo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S129 - S130
  • [46] A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma
    Cristina Encinas
    José-Ángel Hernandez-Rivas
    Albert Oriol
    Laura Rosiñol
    María-Jesús Blanchard
    José-María Bellón
    Ramón García-Sanz
    Javier de la Rubia
    Ana López de la Guía
    Ana Jímenez-Ubieto
    Isidro Jarque
    Belén Iñigo
    Victoria Dourdil
    Felipe de Arriba
    Clara Cuéllar Pérez-Ávila
    Yolanda Gonzalez
    Miguel-Teodoro Hernández
    Joan Bargay
    Miguel Granell
    Paula Rodríguez-Otero
    Maialen Silvent
    Carmen Cabrera
    Rafael Rios
    Adrián Alegre
    Mercedes Gironella
    Marta-Sonia Gonzalez
    Anna Sureda
    Antonia Sampol
    Enrique M. Ocio
    Isabel Krsnik
    Antonio García
    Aránzazu García-Mateo
    Joan-Alfons Soler
    Jesús Martín
    José-María Arguiñano
    María-Victoria Mateos
    Joan Bladé
    Jesús F. San-Miguel
    Juan-José Lahuerta
    Joaquín Martínez-López
    Blood Cancer Journal, 12
  • [47] A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma
    Encinas, Cristina
    Hernandez-Rivas, Jose-Angel
    Oriol, Albert
    Rosinol, Laura
    Blanchard, Maria-Jesus
    Bellon, Jose-Maria
    Garcia-Sanz, Ramon
    de la Rubia, Javier
    Lopez de la Guia, Ana
    Jimenez-Ubieto, Ana
    Jarque, Isidro
    Inigo, Belen
    Dourdil, Victoria
    de Arriba, Felipe
    Cuellar Perez-Avila, Clara
    Gonzalez, Yolanda
    Hernandez, Miguel-Teodoro
    Bargay, Joan
    Granell, Miguel
    Rodriguez-Otero, Paula
    Silvent, Maialen
    Cabrera, Carmen
    Rios, Rafael
    Alegre, Adrian
    Gironella, Mercedes
    Gonzalez, Marta-Sonia
    Sureda, Anna
    Sampol, Antonia
    Ocio, Enrique M.
    Krsnik, Isabel
    Garcia, Antonio
    Garcia-Mateo, Aranzazu
    Soler, Joan-Alfons
    Martin, Jesus
    Arguinano, Jose-Maria
    Mateos, Maria-Victoria
    Blade, Joan
    San-Miguel, Jesus F.
    Lahuerta, Juan-Jose
    Martinez-Lopez, Joaquin
    BLOOD CANCER JOURNAL, 2022, 12 (04)
  • [48] Prognostic Implications of Immune Paralysis in Newly Diagnosed Multiple Myeloma
    Lv, Guoqing
    Tian, Linlin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S581 - S581
  • [49] Efficacy and Prognostic Analysis of Percutaneous Vertebroplasty/Kyphoplasty in Patients with Newly Diagnosed Multiple Myeloma
    Zhang, Fujing
    Liu, Shuzhong
    Zhou, Xi
    Liu, Shuangjiao
    Liu, Yong
    Zhuang, Junling
    BLOOD, 2023, 142
  • [50] Immunoparesis remains a negative prognostic factor in newly diagnosed Multiple Myeloma by competing risk analysis
    Moreno, David
    Isola, Ignacio
    Jimenez, Raquel
    Oliver Caldes, Aina
    Gerardo Rodriguez-Lobato, Luis
    Tovar, Natalia
    Cibeira, M. T.
    Blade, J.
    Rosinol, Laura
    Fernandez De Larrea, C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S135 - S135